SC 13G
FORTE BIOSCIENCES, INC.
- Company
- Forte Biosciences, Inc.
- Filed
- September 12, 2023
- Accession Number
- 0001193125-23-232777
A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →